Healthcare provider profile · identity verified

Troy D Silvernale, DO

Family Practice · GRAND RAPIDS, MI · NPI 1699855908

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	300	57
Amlodipine Besylate	Amlodipine Besylate	294	49
Levothyroxine Sodium	Levothyroxine Sodium	278	49
Lisinopril	Lisinopril	241	33
Quetiapine Fumarate	Quetiapine Fumarate	203	15
Escitalopram Oxalate	Escitalopram Oxalate	187	33
Furosemide	Furosemide	180	34
Carvedilol	Carvedilol	168	18
Citalopram Hbr	Citalopram Hydrobromide	141	18
Omeprazole	Omeprazole	128	34
Gabapentin	Gabapentin	127	26
Buspirone Hcl	Buspirone Hcl	126	17
Eliquis	Apixaban	123	29
Sertraline Hcl	Sertraline Hcl	119	24
Metoprolol Tartrate	Metoprolol Tartrate	112	11
Duloxetine Hcl	Duloxetine Hcl	108	16
Pantoprazole Sodium	Pantoprazole Sodium	107	19
Trazodone Hcl	Trazodone Hcl	107	22
Tamsulosin Hcl	Tamsulosin Hcl	99	21
Finasteride	Finasteride	90	suppressed
Divalproex Sodium	Divalproex Sodium	86	suppressed
Mirtazapine	Mirtazapine	85	20
Simvastatin	Simvastatin	84	suppressed
Losartan Potassium	Losartan Potassium	80	13
Torsemide	Torsemide	79	14
Venlafaxine Hcl	Venlafaxine Hcl	78	suppressed
Metoprolol Succinate	Metoprolol Succinate	75	25
Fluoxetine Hcl	Fluoxetine Hcl	73	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	71	suppressed
Donepezil Hcl	Donepezil Hcl	69	suppressed
Famotidine	Famotidine	67	suppressed
Potassium Chloride	Potassium Chloride	65	14
Clopidogrel	Clopidogrel Bisulfate	60	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	58	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	58	suppressed
Alendronate Sodium	Alendronate Sodium	57	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	57	suppressed
Latanoprost	Latanoprost	57	suppressed
Levetiracetam	Levetiracetam	54	suppressed
Baclofen	Baclofen	53	suppressed
Xarelto	Rivaroxaban	53	suppressed
Memantine Hcl	Memantine Hcl	51	suppressed
Montelukast Sodium	Montelukast Sodium	49	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	47	suppressed
Bupropion Hcl Sr	Bupropion Hcl	46	suppressed
Lorazepam	Lorazepam	45	23
Oxybutynin Chloride Er	Oxybutynin Chloride	43	suppressed
Oxycodone Hcl	Oxycodone Hcl	42	16
Rosuvastatin Calcium	Rosuvastatin Calcium	41	suppressed
Metformin Hcl	Metformin Hcl	40	suppressed
Warfarin Sodium	Warfarin Sodium	40	suppressed
Cephalexin	Cephalexin	39	19
Fluticasone Propionate	Fluticasone Propionate	39	18
Januvia	Sitagliptin Phosphate	39	suppressed
Olanzapine	Olanzapine	38	suppressed
Fentanyl	Fentanyl	35	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	35	16
Tramadol Hcl	Tramadol Hcl	35	24
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	12
Paroxetine Hcl	Paroxetine Hcl	34	suppressed
Benazepril Hcl	Benazepril Hcl	33	suppressed
Bupropion Xl	Bupropion Hcl	32	suppressed
Glipizide	Glipizide	31	suppressed
Atenolol	Atenolol	30	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	30	suppressed
Prednisone	Prednisone	30	suppressed
Hydralazine Hcl	Hydralazine Hcl	29	suppressed
Memantine Hcl Er	Memantine Hcl	28	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	26	suppressed
Risperidone	Risperidone	26	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	15
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Acyclovir	Acyclovir	23	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	22	suppressed
Nystop	Nystatin	21	17
Albuterol Sulfate Hfa	Albuterol Sulfate	20	12
Brimonidine Tartrate	Brimonidine Tartrate	20	suppressed
Clonazepam	Clonazepam	19	suppressed
Digoxin	Digoxin	19	suppressed
Spironolactone	Spironolactone	19	suppressed
Alprazolam	Alprazolam	18	suppressed
Farxiga	Dapagliflozin Propanediol	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Morphine Sulfate	Morphine Sulfate	18	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Amiodarone Hcl	Amiodarone Hcl	16	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	16	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	16	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	16	suppressed
Methocarbamol	Methocarbamol	16	11
Premarin	Estrogens, Conjugated	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	11
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Labetalol Hcl	Labetalol Hcl	14	suppressed
Methotrexate	Methotrexate Sodium	14	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	13	suppressed
Bupropion Hcl	Bupropion Hcl	13	suppressed
Diltiazem Hcl	Diltiazem Hcl	13	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Methadone Hcl	Methadone Hcl	12	suppressed
Raloxifene Hcl	Raloxifene Hcl	12	suppressed
Unifine Safecontrol Pen Needle	Pen Needle,dual Safety,diabetc	12	suppressed
Benztropine Mesylate	Benztropine Mesylate	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error